Abolis

Paris, France · Privately Held (backing)

Developer of a microbial biotechnology platform designed to change production models of high-value molecules. Abolis is based in Paris, France. Its last known valuation is $53.1 million. It has raised $40.1 million.

Last price · $/share
—
Implied valuation
$53.1M
Total raised
$40.1M
Last round
—

Who backs Abolis?

10 investors
InvestorType
Evonik Venture CapitalOther
BOLD (Business Opportunities for L'Oréal Development)—
Clay Capital (Singapore)—
DeepTech & Climate Fonds—
Genopole—
Icos Capital—
Innovation 2030—
Liberset—
Medevice Capital—
ShakeUp Factory—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Abolis investors

10 investors are on record for Abolis, including Evonik Venture Capital, BOLD (Business Opportunities for L'Oréal Development), Clay Capital (Singapore) and DeepTech & Climate Fonds.

Free account
More of Abolis with a free account
  • ·Watch Abolis: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Abolis. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View